Modelling the impact of changes to prescription medicine cost-sharing schemes among middle aged and older adults
Co-payment changes led to average savings of €62 for GMS-eligible participants and €174 for DPS-eligible participants. Although absolute savings were smaller for GMS participants, as the scheme is primarily for low-income populations and the relative expenditure reduction was greater for GMS- than DPS-eligible participants, these savings were likely more impactful for GMS-eligible participants. Further reductions in monthly caps and co-payment charges, particularly for low-income populations, warrant consideration.
Authors
- Tom Fahey (ORCID: https://orcid.org/0000-0002-5896-5783)
- Sara Burke (ORCID: https://orcid.org/0000-0001-9419-1642)
- Rose Anne Kenny (ORCID: https://orcid.org/0000-0002-9336-8124)
- James Larkin (ORCID: https://orcid.org/0000-0003-4339-5623)
- Michelle Flood (ORCID: https://orcid.org/0000-0002-8284-1780)
- Frank Moriarty (ORCID: https://orcid.org/0000-0001-9838-3625)
- Conor Keegan (ORCID: https://orcid.org/0000-0003-1367-1156)
- Fiona Boland (ORCID: https://orcid.org/0000-0003-3228-0046)
- Logan T. Murry (ORCID: https://orcid.org/0000-0003-0345-6997)
- Barbara Clyne (ORCID: https://orcid.org/0000-0002-1186-9495)
- Ciaran Prendergast
- Nav Persaud
Institutions
- St. Michael's Hospital (CA)
- Economic and Social Research Institute (IE)
- Trinity College Dublin (IE)
- St Michael’s Hospital (GB)
- Dublin City University (IE)
Publication Details
- Journal
- Research in Social and Administrative Pharmacy
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1016/j.sapharm.2025.05.012
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00